European epidemiology of kidney cancer

Clicks: 9
ID: 329610
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #113 of 119 articles by views in nephrology dialysis transplantation

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
ABSTRACT Kidney cancer represents a substantial and heterogeneous health burden across Europe. Using contemporary GLOBOCAN 2024 estimates, we provide a granular assessment of kidney cancer epidemiology across European countries, integrating geographical, sex- and age-specific, temporal, and socioeconomic patterns with evidence on risk factors and the relationship between kidney cancer and kidney disease. In 2024, an estimated 116,582 new cases and 42,516 deaths occurred across the countries included. Although the absolute burden was greatest in Western Europe, median country-specific age-standardized incidence rates were highest in Northern and Eastern Europe, illustrating marked geographical heterogeneity. Kidney cancer occurred almost twice as frequently in males as in females, and most cases and deaths occurred after 60 years of age. Incidence has increased or remained stable in most European populations, while mortality has declined or stabilized in many countries. Demographic projections indicate that, if 2024 rates remain unchanged, incident cases may increase by 18.7% and deaths by 38.9% by 2050. Higher incidence in more affluent European countries does not consistently parallel the geographical distribution of established risk factors and may also reflect differences in diagnostic intensity, cancer registration, and healthcare access. Kidney cancer and chronic kidney disease share major metabolic and behavioural risk factors, while epidemiological and experimental evidence supports a potentially bidirectional relationship between kidney injury and renal carcinogenesis. These interactions highlight an important role for nephrology in kidney cancer prevention, preservation of kidney function, and multidisciplinary cancer care.
Reference Key
openalex_W7214164621 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Neriman Sıla Koç
Journal nephrology dialysis transplantation
Year 2026
DOI
10.1093/ndt/gfag216
URL
https://doi.org/10.1093/ndt/gfag216
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.